Vazyme Biotech Co., Ltd. was established in March 2012 with the headquarter located in China. Vazyme has spent a lot in establishing research and development base and IVD aseptic purification workshop in compliance with GMP standards.
Upon the outbreak of COVID-19, Vazyme quickly responded and continues on R&D to optimize All-In COVID-19 solutions. Till March 2021, Vazyme has developed over 15 different COVID-19 detection related products.
Vazyme always focuses on quality and innovation and is devoted to providing excellent products and high-quality services for biomedical and life science research field.
Our mission: Developing technologies to improve human health.